Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcello Mignogna

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Brachytherapy|December 6, 2011
Is prostate-specific antigen percentage decrease predictive of clinical outcome after permanent iodine-125 interstitial brachytherapy for prostate cancer?Mauro Paoluzzi, Marcello Mignogna, Elena Lorenzini, et al.
Brachytherapy|June 24, 2017
Prostate-specific antigen percentage: An early predictive tool after iodine-125 interstitial brachytherapy for prostate cancerMauro Paoluzzi, Andrea Losa, Valentina Cerboneschi, et al.
Turkish Journal of Urology|February 4, 2022
MRI apparent diffusion coefficient (ADC): A biomarker for prostate cancer after radiation therapyMichele Scialpi, Eugenio Martorana, Pietro Scialpi, et al.
Journal of Personalized Medicine|August 27, 2025
The Evolving Landscape of Novel and Old Biomarkers in Localized High-Risk Prostate Cancer: State of the Art, Clinical Utility, and Limitations Toward Precision OncologyLilia Bardoscia, Angela Sardaro, Mariagrazia Quattrocchi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 13, 2009
8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trialErnesto Maranzano, Fabio Trippa, Michelina Casale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trialErnesto Maranzano, Rita Bellavita, Romina Rossi, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|April 11, 2022
Stereotactic radiotherapy for bone oligometastasesCaterina Colosimo, Francesco Pasqualetti, Cynthia Aristei, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2020
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Barbara Alicja Jereczek-Fossa, Matteo Pepa, Giulia Marvaso, et al.
Cancers|August 26, 2022
Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility StudyAntonella Ciabattoni, Fabiana Gregucci, Giuseppe D'Ermo, et al.
Frontiers in Oncology|May 11, 2026
Mixed endometrial carcinoma: is it time to profile the two components separately?Gianna Musettini, Paola Pretelli, Andrea Giusti, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Brachytherapy|December 6, 2011
Is prostate-specific antigen percentage decrease predictive of clinical outcome after permanent iodine-125 interstitial brachytherapy for prostate cancer?Mauro Paoluzzi, Marcello Mignogna, Elena Lorenzini, et al.
Brachytherapy|June 24, 2017
Prostate-specific antigen percentage: An early predictive tool after iodine-125 interstitial brachytherapy for prostate cancerMauro Paoluzzi, Andrea Losa, Valentina Cerboneschi, et al.
Turkish Journal of Urology|February 4, 2022
MRI apparent diffusion coefficient (ADC): A biomarker for prostate cancer after radiation therapyMichele Scialpi, Eugenio Martorana, Pietro Scialpi, et al.
Journal of Personalized Medicine|August 27, 2025
The Evolving Landscape of Novel and Old Biomarkers in Localized High-Risk Prostate Cancer: State of the Art, Clinical Utility, and Limitations Toward Precision OncologyLilia Bardoscia, Angela Sardaro, Mariagrazia Quattrocchi, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 13, 2009
8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trialErnesto Maranzano, Fabio Trippa, Michelina Casale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 2, 2005
Short-course versus split-course radiotherapy in metastatic spinal cord compression: results of a phase III, randomized, multicenter trialErnesto Maranzano, Rita Bellavita, Romina Rossi, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|April 11, 2022
Stereotactic radiotherapy for bone oligometastasesCaterina Colosimo, Francesco Pasqualetti, Cynthia Aristei, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 16, 2020
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)Barbara Alicja Jereczek-Fossa, Matteo Pepa, Giulia Marvaso, et al.
Cancers|August 26, 2022
Patterns of Care for Breast Radiotherapy in Italy: Breast IRRadiATA (Italian Repository of Radiotherapy dATA) Feasibility StudyAntonella Ciabattoni, Fabiana Gregucci, Giuseppe D'Ermo, et al.
Frontiers in Oncology|May 11, 2026
Mixed endometrial carcinoma: is it time to profile the two components separately?Gianna Musettini, Paola Pretelli, Andrea Giusti, et al.
Pageof 2